S100A4
Protein S100-A4
Also known as: 18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98, S10A4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26447
- Gene
- S100A4
- Ensembl
- ENSG00000196154
- Chromosome
- 1
- Canonical length
- 101 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Cytosol
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in motility, invasion, and tubulin polymerization. Chromosomal rearrangements and altered expression of this gene have been implicated in tumor metastasis. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
101 residues, UniProt reviewed canonical sequence.
>P26447|S100A4
1 MACPLEKALD VMVSTFHKYS GKEGDKFKLN KSELKELLTR ELPSFLGKRT DEAAFQKLMS
61 NLDSNRDNEV DFQEYCVFLS CIAMMCNEFF EGFPDKQPRK KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against S100A4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 2,004 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 2,004 nTPM
- adipose tissue: 1,199 nTPM
- bone marrow: 1,028 nTPM
- lung: 856 nTPM
- breast: 680 nTPM
- cervix: 610 nTPM
Single-cell type
- ocular epithelial cells: 8,610 nCPM
- neutrophils: 4,487 nCPM
- monocytes: 3,839 nCPM
- megakaryocytes: 2,875 nCPM
- decidual stromal cells: 2,842 nCPM
- cdc: 2,552 nCPM
Immune cell
- total PBMC: 24,123 nTPM
- classical monocyte: 13,587 nTPM
- neutrophil: 12,218 nTPM
- non-classical monocyte: 11,930 nTPM
- myeloid DC: 9,294 nTPM
- intermediate monocyte: 9,128 nTPM
Brain region
- thalamus: 23 nTPM
- white matter: 23 nTPM
- medulla oblongata: 18 nTPM
- choroid plexus: 18 nTPM
- cerebral cortex: 17 nTPM
- pons: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.86
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.36
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- actin binding
- calcium ion binding
- calcium-dependent protein binding
- chemoattractant activity
- identical protein binding
- RAGE receptor binding
- RNA binding
- transition metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of S100A4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads S100A4 as an antibody target. Whether an autoantibody or antibody against S100A4 could matter depends on whether native S100A4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
S100A4 is annotated as secreted, so native S100A4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label S100A4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...